Aktiesnakken — Januar 2012
-
De udarbejder et fint regneark, og det virker..
-
-
-
wtf
-
-
og så "Interim report Q3 2011 xls"
-
jeg vil helst ikke have nohope med i dem. så skal jeg hører for det
-
Equity per share 10,05€
-
ved det, har du fortalt hende om genmab?
-
eller er du for fin tl det
-
jeg har dem
-
og vil godt have flere
-
det er også charmen ved dem
-
once your tried mab you never go back
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind